), a leading immuno-oncology company, today announced that it has entered into a new collaboration agreement with Japan's CYTLIMIC, a recent spin off from NEC Corporation (NEC), to test a cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results